Circulating concentrations of insulin-like growth factor-1 in dogs with naturally occurring mitral regurgitation

Journal of Veterinary Internal Medicine

Volumn 19, Issue 4, 2005, Pages 528-532

  Pedersen, Henrik D ^a,c   Falk, Torkel ^a   Häggström, Jens ^b   Tarnow, Inge ^a   Olsen, Lisbeth H ^a   Kvart, Clarence ^b   Nielsen, Mette O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Canine; Heart failure; Mitral valve prolapse; Pathophysiology; Serum insulin like growth factor 1

Indexed keywords

SOMATOMEDIN C;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; DOG; DOG DISEASE; FEMALE; MALE; METABOLISM; MITRAL VALVE REGURGITATION;

ANIMALS; DOG DISEASES; DOGS; FEMALE; HEART FAILURE, CONGESTIVE; INSULIN-LIKE GROWTH FACTOR I; MALE; MITRAL VALVE INSUFFICIENCY;

CANIS FAMILIARIS;

EID: 23744487882     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19[528:CCOIGF]2.0.CO;2     Document Type: Article

References (39)

1. Saccà L, Fazio S, Longobardi S, Cittadini A. Cardiac effects of growth hormone in physiology and in heart failure. Endocr J 1999;46:S5-S10.
2. Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin Endocrinol 2001;54:137-154.
3. Böger RH. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans. J Endocrinol Invest 1999;22:75-81.
4. Kinugawa S, Tsutsui H, Ide T, et al. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc Res 1999;43:157-164.
5. Tsukahara H, Gordienko DV, Tonshoff B, et al. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994;45:598-604.
6. Napoli R, Guardasole V, Matarazzo M, et al. Growth hormone corrects vascular dysfunction in patients with heart failure. J Am Coll Cardiol 2002;39:90-95.
7. Giustina A, Volterrani M, Manelli F, et al. Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure. Am Heart J 1999;137:1035-1043.
8. Osterziel KJ, Ranke MB, Strohm O, Dietz R. The somatotrophic system in patients with dilated cardiomyopathy: Relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function. Clin Endocrinol 2000;53:61-68.
9. Al-Obaidi MK, Hon JKF, Stubbs PJ, et al. Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure. Am Heart J 2001;142:e10.
10. Broglio F, Fubini A, Morello M, et al. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin Endocrinol 1999;50:417-430.
11. Anwar A, Gaspoz JM, Pampallona S, et al. Effect of congestive heart failure on the insulin-like growth factor-1 system. Am J Cardiol 2002;90:1402-1405.
12. Anker SD, Volterrani M, Pflaum C-D, et al. Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone. J Am Coll Cardiol 2001;38:443-452.
13. Hambrecht R, Schulze PC, Gielen S, et al. Reduction of insulin-like growth factor-1 expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol 2002;39:1175-1181.
14. Mangieri E, Croce CT, Tanzilli G, et al. Growth hormone and insulin-like growth factor 1 in normopituitaric patients with various degrees of heart failure. Ann N Y Acad Sci 1995;752:429-431.
15. Corbalan R, Acevedo M, Godoy I, et al. Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure. J Card Fail 1998;4:115-119.
16. Shen Y-T, Woltmann RF, Appleby S, et al. Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure. Am J Physiol 1998;274:H456-H466.
17. Lee W-L, Chen J-W, Ting C-T, et al. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology 1999;140:4831-4840.
18. Freeman LM, Rush JE, Kehayia JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998;12:440-448.
19. Pedersen HD, Häggström J, Olsen LH, et al. Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait. J Vet Intern Med 2002;16:169-173.
20. Pedersen HD, Schütt T, Søndergaard R. et al. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation. J Vet Intern Med 2003;17:178-184.
21. Haggstrom J, Hansson K, Kvart C, et al. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res 1997;58:77-82.
22. Renehan AG, Jones J, O'Dwyer ST, Shalet SM. Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: Comparisons using the Bland-Altman method. Growth Horm IGF Res 2003;13:341-346.
23. Delafontaine P, Lou H, Harrison DG, Bernstein KE. Sequence of a cDNA encoding dog insulin-like growth factor I. Gene 1993;130:305-306.
24. Frey RS, Hathaway MR, Dayton WR. Comparison of the effectiveness of various procedures for reducing or eliminating insulin-like growth factor-binding protein interference with insulin-like growth factor-I radioimmunoassays on porcine sera. J Endocrinol 1994;140:229-237.
25. Plaut K, Cohick WS, Bauman DE, Baxter RC. Evaluation of interference by insulin-like growth factor I (IGF-I) binding proteins in a radioimmunoassay for IGF-I in serum from dairy cows. Domest Anim Endocrinol 1991;8:393-405.
26. Riis PM, Nielsen MO, Jacobsen J. Effect of lactation, pregnancy and somatotropin treatment on plasma IGF-1 concentrations, IGF-1 partition between binding protein groups and binding protein pattern in goats. Acta Agric Scand A-AN 1998;48:19-27.
27. Cornell CC, Kittleson MD, Torre PD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 2004;18:311-321.
28. Delafontaine P, Brink M. The growth hormone and insulin-like growth factor 1 axis in heart failure. Ann Endocrinol (Paris) 2000;61:22-26.
29. Serneri GGN, Boddi M, Cecioni I, et al. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 2001;88:961-968.
30. Eigenmann JE, Patterson DF, Zapf J, Froesch ER. Insulin-like growth factor I in the dog: A study in different dog breeds and in dogs with growth hormone elevation. Acta Endocrinol (Copenhagen) 1984;105:294-301.
31. Khan AS, Sane DC, Wannenburg T, Sonntag WE. Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res 2002;54:25-35.
32. Tivesten Å, Caidahl K, Kujacic V, et al. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Growth Horm IGF Res 2001;11:187-195.
33. Isgaard J, Bergh C-H, Caidahl K, et al. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 1998;19:1704-1711.
34. Osterziel KJ, Strohm O, Schuler J, et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998;351:1233-1237.
35. Osterziel KJ, Blum WF, Strohm O, Dietz R. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration. J Clin Endocrinol Metab 2000;85:1533-1539.
36. Acevedo M, Corbalán R, Chamorro G, et al. Administration of growth hormone to patients with advanced cardiac heart failure: Effects upon left ventricular function, exercise capacity, and neurohormonal status. Int J Cardiol 2003;87:185-191.
37. Speakman JR, Booles D, Butterwick R. Validation of dual energy X-ray absorptiometry (DXA) by comparison with chemical analysis of dogs and cats. Int J Obes 2001;25:439-447.
38. Lauten SD, Cox NR, Brawner WR Jr, Baker HJ. Use of dual energy X-ray absorptiometry for non-invasive body composition measurements in clinically normal dogs. Am J Vet Res 2001;62:1295-1301.
39. de Laforcade AM, Freeman LM, Rush JE. Serum nitrate and nitrite in dogs with spontaneous cardiac disease. J Vet Intern Med 2003;17:315-318.